These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
848 related articles for article (PubMed ID: 12085361)
21. Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans. Hirano M; Maeda K; Shitara Y; Sugiyama Y J Pharmacol Exp Ther; 2004 Oct; 311(1):139-46. PubMed ID: 15159445 [TBL] [Abstract][Full Text] [Related]
22. Substrate-dependent inhibition of organic anion transporting polypeptide 1B1: comparative analysis with prototypical probe substrates estradiol-17β-glucuronide, estrone-3-sulfate, and sulfobromophthalein. Izumi S; Nozaki Y; Komori T; Maeda K; Takenaka O; Kusano K; Yoshimura T; Kusuhara H; Sugiyama Y Drug Metab Dispos; 2013 Oct; 41(10):1859-66. PubMed ID: 23920221 [TBL] [Abstract][Full Text] [Related]
23. Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport. Svoboda M; Wlcek K; Taferner B; Hering S; Stieger B; Tong D; Zeillinger R; Thalhammer T; Jäger W Biomed Pharmacother; 2011 Sep; 65(6):417-26. PubMed ID: 21719246 [TBL] [Abstract][Full Text] [Related]
24. Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Cui Y; König J; Keppler D Mol Pharmacol; 2001 Nov; 60(5):934-43. PubMed ID: 11641421 [TBL] [Abstract][Full Text] [Related]
25. Predominant contribution of rat organic anion transporting polypeptide-2 (Oatp2) to hepatic uptake of beta-lactam antibiotics. Nakakariya M; Shimada T; Irokawa M; Koibuchi H; Iwanaga T; Yabuuchi H; Maeda T; Tamai I Pharm Res; 2008 Mar; 25(3):578-85. PubMed ID: 17891554 [TBL] [Abstract][Full Text] [Related]
26. Characterization and identification of steroid sulfate transporters of human placenta. Ugele B; St-Pierre MV; Pihusch M; Bahn A; Hantschmann P Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E390-8. PubMed ID: 12409283 [TBL] [Abstract][Full Text] [Related]
27. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans. Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871 [TBL] [Abstract][Full Text] [Related]
30. The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3beta in hepatocellular carcinoma. Vavricka SR; Jung D; Fried M; Grützner U; Meier PJ; Kullak-Ublick GA J Hepatol; 2004 Feb; 40(2):212-8. PubMed ID: 14739090 [TBL] [Abstract][Full Text] [Related]
31. Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III. Bednarczyk D; Boiselle C Xenobiotica; 2016; 46(5):457-66. PubMed ID: 26383540 [TBL] [Abstract][Full Text] [Related]
32. Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase. Fujino H; Saito T; Ogawa S; Kojima J J Pharm Pharmacol; 2005 Oct; 57(10):1305-11. PubMed ID: 16259759 [TBL] [Abstract][Full Text] [Related]
33. Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity. Nozawa T; Sugiura S; Nakajima M; Goto A; Yokoi T; Nezu J; Tsuji A; Tamai I Drug Metab Dispos; 2004 Mar; 32(3):291-4. PubMed ID: 14977862 [TBL] [Abstract][Full Text] [Related]
34. Active influx transport is mediated by members of the organic anion transporting polypeptide family in human epidermal keratinocytes. Schiffer R; Neis M; Höller D; Rodríguez F; Geier A; Gartung C; Lammert F; Dreuw A; Zwadlo-Klarwasser G; Merk H; Jugert F; Baron JM J Invest Dermatol; 2003 Feb; 120(2):285-91. PubMed ID: 12542534 [TBL] [Abstract][Full Text] [Related]
35. Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes. Hagenbuch B; Scharschmidt BF; Meier PJ Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):901-4. PubMed ID: 8670169 [TBL] [Abstract][Full Text] [Related]
36. Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions. Sharma P; Holmes VE; Elsby R; Lambert C; Surry D Xenobiotica; 2010 Jan; 40(1):24-37. PubMed ID: 19919292 [TBL] [Abstract][Full Text] [Related]
37. Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo. Durmus S; Lozano-Mena G; van Esch A; Wagenaar E; van Tellingen O; Schinkel AH Mol Pharm; 2015 Dec; 12(12):4259-69. PubMed ID: 26474710 [TBL] [Abstract][Full Text] [Related]
38. Novel cationic and neutral glycocholic acid and polyamine conjugates able to inhibit transporters involved in hepatic and intestinal bile acid uptake. Vicens M; Medarde M; Macias RI; Larena MG; Villafaina A; Serrano MA; Marin JJ Bioorg Med Chem; 2007 Mar; 15(6):2359-67. PubMed ID: 17276074 [TBL] [Abstract][Full Text] [Related]
39. Organic anion transporting polypeptide-mediated transport of, and inhibition by, asunaprevir, an inhibitor of hepatitis C virus NS3 protease. Eley T; Han YH; Huang SP; He B; Li W; Bedford W; Stonier M; Gardiner D; Sims K; Rodrigues AD; Bertz RJ Clin Pharmacol Ther; 2015 Feb; 97(2):159-66. PubMed ID: 25670521 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors. Khurana V; Minocha M; Pal D; Mitra AK Drug Metabol Drug Interact; 2014; 29(4):249-59. PubMed ID: 24807167 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]